Advancing vaccine development through green biotechnology

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

WuXi Bi­o­log­ics tout­ed its part­ner­ships and con­tracts in its an­nu­al re­port on Tues­day, not­ing that it has al­most 700 projects in its pipeline, which can